Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Dan Stanzione On Supercomputers, Pandemic Computing, and Predicting Hardware Needs

    Jan 19, 2021, 01:00 AM by User Not Found
    Bio-IT World | TRENDS FROM THE TRENCHES—Dan Stanzione has been working at the Texas Advanced Computing Center in Austin for three quarters of its 19-year tenure. Now the executive director and associate vice president of research, Stanzione runs TACC as both the research computing arm of the University of Texas as well as an independent National Science Foundation-funded supercomputing center. He sat down with Stan Gloss to talk about big compute, pandemics, and technology trends.
    Full story
  • Oxford Nanopore, NVIDIA Partner on GPU-Powered PromethION

    Jan 15, 2021, 17:42 PM by User Not Found
    Bio-IT World | Oxford Nanopore Technologies and NVIDIA announced a collaboration this week to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale and can also analyze any length fragment of DNA/RNA.
    Full story
  • PacBio: Year of Expansion, Whole-Genome Clinical Goals

    Jan 15, 2021, 11:48 AM by User Not Found
    Bio-IT World | At the J.P. Morgan Healthcare Conference yesterday, PacBio’s new CEO, laid out a route to the clinic for PacBio’s HiFi sequencing reads, and set a 2021 goal of expansion across the business: improving commercial footprint, driving product development pipelines, and establishing market leadership in whole-genome clinical sequencing.
    Full story
  • Novel, Short Form of ACE2, AI Learns ‘Language’ of Viral Mutations, Odd Structure of ORF8: COVID-19 Updates

    Jan 14, 2021, 18:13 PM by User Not Found
    Bio-IT World I Single-dose nanoparticle vaccine triggers strong immune response in mice, mapping the unique structure of SARS-CoV-2 ORF8 protein, COVID-19 may eventually become as mild as common cold. Plus: Human lung bronchioalveolar tissue model successfully demonstrates viral replication along with potential therapy and mitochondria one of the first lines of defense.
    Full story
  • 10x Genomics’ Million Cell Platform, High Def Spatial Transcriptomics, More

    Jan 14, 2021, 01:00 AM by User Not Found
    Bio-IT World | Serge Saxonov, CEO and co-founder of 10x Genomics, painted a rosy picture of the future of single-cell technologies at the J.P. Morgan Healthcare Conference. And 10x has the product suite to enable that future, including a new version of the Chromium platform, a higher resolution version of the Visium platform, a coming In Situ platform, a wider rollout of the 10x Cloud, and new tools to address sample prep and cost.
    Full story
  • PacBio, Invitae Announce Plans To Build New Sequencing Platform

    Jan 13, 2021, 16:28 PM by User Not Found
    Bio-IT World | Pacific Biosciences and Invitae today announced a multi-year collaboration to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate HiFi sequencing to expand Invitae’s whole genome testing capabilities.
    Full story
  • Reversing The Aging Clock With Epigenetic Reprogramming

    Jan 13, 2021, 14:27 PM by User Not Found
    Bio-IT World | As aging researchers are aware, “birthday candles are not a good guide” to either human health or longevity. But there is an abundance of clues in the genome and, as suggested by studies in animals, some of age-related damage is reversible by removing or reprogramming problematic cells or blocking the activity of key proteins.
    Full story
  • Illumina at JPM: Cloud Analytics Platform, More Diagnostics Focus, Sequencing Updates To Come

    Jan 11, 2021, 18:50 PM by User Not Found
    Bio-IT World | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, made partnership announcements, and launched Illumina Connected Analytics, an expanding software analytics platform. deSouza did not announce any new sequencing platforms, though he teased updates coming in 2021.
    Full story
  • BOC Sciences comprehensively deploys liposomal drug delivery research to seek industry-wide cooperation

    Jan 11, 2021, 14:35 PM by
    Full story
  • European Medicines Agency Selects Panalgo for Real-World Data Analytics

    Jan 11, 2021, 14:35 PM by
    The EMA will use Panalgo’s Instant Health Data (IHD) platform to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
    Full story
  • Seqster Releases v7.1 on Azure

    Jan 11, 2021, 13:27 PM by User Not Found
    Bio-IT World | Kicking off news from the J.P. Morgan 39th Annual Healthcare Conference, Seqster announced the release of Seqster Platform v7.1 on the Microsoft Azure cloud this morning.
    Full story
  • Math Model Predicts Optimal Treatments, Reducing Infectious Period Could Save Millions, Illumina Tracks Variants: COVID-19 Updates

    Jan 8, 2021, 01:00 AM by User Not Found
    Bio-IT World I New hybrid approach identifies existing drugs that could be repurposed to treat SARS-CoV-2 and Cellid signs research contract with the International Vaccine Institute to expedite clinical development of “AdCLD-CoV-19” COVID-19 vaccine. Plus: Illumina and Helix will track the emergence and prevalence of new strains, including the highly transmissible B.1.1.7 variant.
    Full story
  • Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London

    Jan 7, 2021, 11:26 AM by
    Panthera’s clinical trial sites are helping to evaluate an alternative AstraZeneca vaccine for people who are unable to have the currently approved Covid-19 vaccines. The treatment is aimed at helping those people with a compromised immune system, who cannot be vaccinated, vaccine hesitant and those who are unlikely to respond to a vaccination.
    Full story
  • Enveda Biosciences Systematically Harnesses Untapped Potential of Nature’s Chemistry to Develop Next-Gen Therapeutics

    Jan 7, 2021, 11:26 AM by
    Full story
  • ComputaBio Has Launched Molecular Dynamics Simulation Services for Drug R&D Projects

    Jan 7, 2021, 11:25 AM by
    ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.
    Full story
  • Octapharma Selects Model N Revenue Cloud for Life Sciences

    Jan 7, 2021, 11:25 AM by
    Full story
  • Trendspotting: What’s Coming For Bio-IT In 2021

    Jan 7, 2021, 01:00 AM by User Not Found
    Bio-IT World | When we spoke with the Bio-IT World vendor community, leaders reported working hard to synthesize what 2020 brought us and apply those learnings to 2021. As they each made predictions in their own business areas, some themes arose.
    Full story
  • Charles River Labs Acquires Distributed Bio

    Jan 6, 2021, 18:36 PM by User Not Found
    Bio-IT World | Charles River Laboratories acquired Distributed Bio on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018.
    Full story
  • Bizarre Effects Of Sound Waves Could Benefit Drug Delivery, Exosome Therapy

    Jan 6, 2021, 01:00 AM by User Not Found
    Bio-IT World | Scientists at RMIT University in Melbourne, Australia, have developed a nebulizer for delivering drugs and vaccines to the lungs by generating high-frequency sound waves on a microchip. Serendipitously, the device generates droplets “just the right size”—between 1 and 5 microns—for large molecules such as DNA and antibodies to reach the deep lungs.
    Full story
  • WGS Market Foothold, New Life Sciences Doc Management, Algorithm For Neoantigen ID, More

    Jan 4, 2021, 09:56 AM by User Not Found
    Bio-IT World | Illumina and Harvard Pilgrim announce risk sharing for whole genome sequencing, new cryo-EM from Thermo Fisher, LSBio acquires Absolute Antibody, Presearch digitizes hand-written lab notes, and more.
    Full story
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189 (current)
  • 190
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy